ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,036, issued on Oct. 7, was assigned to Terran Biosciences Inc. (Miami Beach, Fla.).

"Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amine" was invented by Matthew Duncton (Las Vegas) and Samuel Clark (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to salt and solid forms of (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE and methods of treating neurological disorder and/or a psychiatric disorder in a subject in need thereof."

The patent was filed on May 16, 2024, under Application No. 18/666,109.

*For further information, including images, charts and tables, please v...